Lohist-d Liquid
Product Images NDC 68047-159

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lohist-d (NDC 68047-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Larken Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 01)

Drug Facts panel for LoHist-D oral liquid, an antihistamine nasal decongestant containing chlorpheniramine maleate 2 mg and pseudoephedrine HCl 30 mg per 5 ml teaspoonful. The label details uses for relief of hay fever symptoms, warnings including not to sedate children or combine with MAO inhibitors, and instructions to consult a doctor for certain medical conditions or prolonged symptoms. The panel also advises avoiding alcohol and cautions about drowsiness and other side effects.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.